Lata Medical Research Foundation, Nagpur, India.
PLoS One. 2010 Apr 28;5(4):e10386. doi: 10.1371/journal.pone.0010386.
For over a decade, the importance of zinc in the treatment of acute and persistent diarrhea has been recognized. In spite of recently published reviews, there remain several unanswered questions about the role of zinc supplementation in childhood diarrhea in the developing countries. Our study aimed to assess the therapeutic benefits of zinc supplementation in the treatment of acute or persistent diarrhea in children, and to examine the causes of any heterogeneity of response to zinc supplementation.
EMBASE, MEDLINE and CINAHL databases were searched for published reviews and meta-analyses on the use of zinc supplementation for the prevention and treatment of childhood diarrhea. Additional RCTs published following the meta-analyses were also sought. The reviews and published RCTs were qualitatively mapped followed by updated random-effects meta-analyses, subgroup meta-analyses and meta-regression to quantify and characterize the role of zinc supplementation with diarrhea-related outcomes. We found that although there was evidence to support the use of zinc to treat diarrhea in children, there was significant unexplained heterogeneity across the studies for the effect of zinc supplementation in reducing important diarrhea outcomes. Zinc supplementation reduced the mean duration of diarrhea by 19.7% but had no effect on stool frequency or stool output, and increased the risk of vomiting. Our subgroup meta-analyses and meta-regression showed that age, stunting, breast-feeding and baseline zinc levels could not explain the heterogeneity associated with differential reduction in the mean diarrheal duration. However, the baseline zinc levels may not be representative of the existing zinc deficiency state.
Understanding the predictors of zinc efficacy including the role of diarrheal disease etiology on the response to zinc would help to identify the populations most likely to benefit from supplementation. To improve the programmatic use of zinc, further evaluations of the zinc salts used, the dose, the frequency and duration of supplementation, and its acceptability are required. The significant heterogeneity of responses to zinc suggests the need to revisit the strategy of universal zinc supplementation in the treatment children with acute diarrhea in developing countries.
十多年来,人们已经认识到锌在治疗急性和持续性腹泻中的重要性。尽管最近发表了一些综述,但发展中国家儿童腹泻补锌治疗的作用仍存在一些未解决的问题。我们的研究旨在评估补锌治疗儿童急性或持续性腹泻的治疗效果,并探讨对锌补充治疗反应存在差异的原因。
我们在 EMBASE、MEDLINE 和 CINAHL 数据库中检索了关于锌补充剂用于预防和治疗儿童腹泻的已发表综述和荟萃分析。还寻找了在这些荟萃分析之后发表的 RCT。对综述和已发表的 RCT 进行定性映射,然后进行更新的随机效应荟萃分析、亚组荟萃分析和荟萃回归,以量化和描述与腹泻相关结局的锌补充治疗作用。我们发现,尽管有证据支持使用锌治疗儿童腹泻,但在研究中锌补充对减少重要腹泻结局的影响存在显著的无法解释的异质性。锌补充剂可使腹泻平均持续时间缩短 19.7%,但对粪便频率或粪便量没有影响,反而增加呕吐的风险。我们的亚组荟萃分析和荟萃回归表明,年龄、发育迟缓、母乳喂养和基线锌水平不能解释与平均腹泻持续时间差异减少相关的异质性。然而,基线锌水平可能不能代表现有的锌缺乏状态。
了解锌疗效的预测因素,包括腹泻病因对锌反应的作用,将有助于确定最有可能从补充中受益的人群。为了改进锌的方案使用,需要进一步评估所使用的锌盐、剂量、补充的频率和持续时间及其可接受性。对锌反应存在显著的异质性表明,有必要重新考虑在发展中国家对急性腹泻儿童普遍补锌的策略。